Literature DB >> 31472296

Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma.

Ayobami Akenroye1, Corinne Keet2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31472296     DOI： 10.1016/j.jaip.2019.08.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  Asthma biologic trial eligibility and real-world outcomes in the United States.

Authors:  Regina W Lam; Jonathan W Inselman; Molly M Jeffery; Jacob T Maddux; Nilay D Shah; Matthew A Rank
Journal:  J Asthma       Date:  2021-12-06

2.  Asthma Patients Who Stop Asthma Biologics Have a Similar Risk of Asthma Exacerbations as Those Who Continue Asthma Biologics.

Authors:  Molly M Jeffery; Jonathan W Inselman; Jacob T Maddux; Regina W Lam; Nilay D Shah; Matthew A Rank
Journal:  J Allergy Clin Immunol Pract       Date:  2021-02-27

3.  Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma.

Authors:  Saad AlShareef; Christine F McDonald; Joy Lee
Journal:  J Asthma Allergy       Date:  2022-02-15

4.  Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement.

Authors:  Neeta Thakur; Stephanie Lovinsky-Desir; Donna Appell; Christian Bime; Lauren Castro; Juan C Celedón; Juliana Ferreira; Maureen George; Yolanda Mageto; Arch G Mainous III; Smita Pakhale; Kristin A Riekert; Jesse Roman; Elizabeth Ruvalcaba; Sunil Sharma; Priya Shete; Juan P Wisnivesky; Fernando Holguin
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 21.405
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.